• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MILTENYI BIOTEC GMBH CLINIMACS PLUS INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MILTENYI BIOTEC GMBH CLINIMACS PLUS INSTRUMENT Back to Search Results
Model Number CLINIMACS PLUS INSTRUMENT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Insufficiency (2022); Respiratory Distress (2045); Chest Tightness/Pressure (2463); Pericardial Effusion (3271)
Event Date 09/27/2016
Event Type  Injury  
Event Description
Pt is a (b)(6) y/o male with history of recurrent hodgkin lymphoma.He received a tcr-alpha/beta and cd19 depleted haploidentical stem cell transplant on (b)(6) 2016.The pt was seen in clinic for routine f/u and had been experiencing chest discomfort with deep breaths and worsening cough.The pt was admitted to the inpatient unit on oxygen.Echocardiogram showed pericardial effusion, with concern for tamponade.Chest ct showed worsening upper lobe predominant ground glass opacities.Cardiology did not feel pericardiocentesis was needed emergently, but, performed it next morning and drain placed.The following day ((b)(6) 2016), there was reaccumulation of the effusion, suspected to be a blockage which was resolved with flushing.Echo on ( (b)(6) 2016 showed trivial effusion.Cardiac mri on (b)(6) 2016 showed constrictive pericarditis.Drain was removed on (b)(6) 2016.Repeat echo on (b)(6) 2016 showed no pericardial effusion.Cardiology recommended repeat echo in 2 weeks.The pt was discharged and is so far clinically stable as an outpatient.We are reporting this event because it was a serious adverse event that is relatively unexpected with the transplant regimen.We suspect that the reason for this complication might be a combination of his prior and recent chemo/radiation.We do not feel the device (clinimacs column) to be related at all.However, given the fact that the ide encompassed the entire conditioning regimen, we are still reporting this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINIMACS PLUS INSTRUMENT
Type of Device
CLINIMACS PLUS INSTRUMENT
Manufacturer (Section D)
MILTENYI BIOTEC GMBH
MDR Report Key6030470
MDR Text Key57680642
Report NumberMW5065401
Device Sequence Number1
Product Code OVG
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberCLINIMACS PLUS INSTRUMENT
Device Catalogue Number151-01
Type of Device Usage N
Patient Sequence Number1
Treatment
ACETAMINOPHEN; ACYCLOVIR; ALBUTEROL; AMBIEN; AUTOLOGOUS STEM CELL; AZITHROMYCIN; BACTRIM; BRENTUXIMAB; BUDESONIDE-FORMOTEROL; CARBOPLATIN; CARVEDILOL; COLCHICINE; COMPAZINE; ETOPOSIDE CHEMOTHERAPY; FLUCONAZOLE; FUROSEMIDE; IBUPROFEN; IFOSFAMIDE; LEVOTHYROXINE; LIDOCAINE-PRILOCAINE; LISINOPRIL; LOPERAMIDE; MONTELUKAST; NIVOLUMAB; OXYBUTYNIN; OXYCODONE; PREDNISONE; RADITION; RANITIDINE; SIROLIMUS
Patient Outcome(s) Hospitalization;
Patient Age29 YR
Patient Weight156
-
-